Q1 FY27 results - standalone loss, ICD extension, new auditor

Pat NegativeRelated Party TransactionsContingent Liabilities IncreasedExceptional ItemResults RestatedResults View source PDF Explain this filing

ZUARI · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.4%Reaction day

₹237.50

prior close

₹239.11

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.1%-2.5% vs market

Fertilizers peers, median of 21sector+0.1%-1.6% vs sector

On the reaction day the stock moved 2.5 pts less than Nifty Microcap 250 and 1.6 pts less than its Fertilizers peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.3

10m

-0.4

15m

-0.5

30m

-1.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.4+1.1-2.5+0.1-1.6

Next day

-1.9+2.4-4.3+1.0-2.9

-2.7+2.9-5.6+0.4-3.0

-4.2+4.2-8.4+0.1-4.4

-4.8+4.6-9.4+0.3-5.2

-4.6+4.6-9.2-0.3-4.4

-4.6+4.4-9.0+0.4-5.0

15d

-5.7+5.7-11.4-1.4-4.3

-2.7+6.6-9.3-1.8-0.9

-7.8+5.4-13.2-5.0-2.8

—————

UpDownMarket · Nifty Microcap 250Sector · Fertilizers peers, median of 21Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved Q1 FY27 standalone and consolidated results. Auditor issued unmodified review. Figures not comparable with prior year as MCFL ceased to be a subsidiary from September 2025. Standalone results show a loss. Company seeks six-month extension on Rs 95 Crore ICD from related party Zuari Industries, signalling liquidity strain. Appointed SNSK & Associates as internal auditor. Faces Rs 296.46 Crore disputed water charge demand being contested in High Court.

Likely market impact

Standalone loss and large disputed demand raise concerns; ICD extension signals cash need; results not comparable year-on-year.